Atezolizumab compared to chemotherapy for first-line treatment in non-small cell lung cancer with high PD-L1 expression: a cost-effectiveness analysis from US and Chinese perspectives
2021 ◽
Vol 0
(0)
◽
pp. 0-0
Shuqiao Cheng
◽
Rui Pei
◽
Jianhuang Li
◽
Bin Li
◽
Lanhua Tang
◽
...
J. Verma
◽
D. Verma
◽
A. Maria
2021 ◽
Vol Volume 13
◽
pp. 4263-4270
Longfeng Zhang
◽
Na Li
◽
Maobai Liu
◽
Bin Zheng
◽
Zhijuan Wu
◽
...
J. Verma
◽
D. Verma
◽
A. Maria
2009 ◽
Vol 12
(7)
◽
pp. A278-A279
L Guidi
◽
S Malik
◽
D Valle
◽
Y Asukai
◽
K Taipale
2020 ◽
Vol 37
(5)
◽
pp. 2116-2126
◽
Dong Ding
◽
Huabin Hu
◽
Mengting Liao
◽
Yin Shi
◽
Longjiang She
◽
...
C. Chouaid
◽
L. Bensimon
◽
A. Millier
◽
E. Clay
◽
R. Insinga
◽
...
2020 ◽
Vol 146
◽
pp. 385-386
Min Huang
◽
Ralph P. Insinga
◽
Thomas Burke
◽
Ying Zhang
◽
Gilberto de Lima Lopes
2010 ◽
Vol 13
(7)
◽
pp. A270
◽
J Jacob
◽
M Henriksson
◽
D Brattström
2018 ◽
Vol 4
(8)
◽
pp. 1080
◽
Pedro N. Aguiar
◽
Benjamin Haaland
◽
Wungki Park
◽
Pui San Tan
◽
Auro del Giglio
◽
...
E. Öksüz
◽
S. Malhan
◽
L. Yanik
◽
E. Koc
◽
E. Erdogan-Ciftci
◽
...
Close
Export Citation Format
Close
Share Document
Close